+0.98%
Today
Loading 1D prices…
Company profile
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Morristown, NJ, United States
Employees
32
Fiscal year end
1231
CIK
1422142
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| NGENNervGen Pharma Corp. Common stock | $234.9M | — | — | -$0.61 | +1.16% | Buy |
| VRXAVeraxa Biotech AG Ordinary Shares | $233.3M | — | — | -$0.1989 | +0.61% | Unrated |
| NATRNature's Sunshine Products Inc. Common Stock | $238.4M | $480.1M | +4.07% | $1.06 | -0.44% | Buy |
| ADAGAdagene Inc. American Depositary Shares | $228.3M | $7.7M | -229.56% | -$0.30 | +2.72% | Buy |
| GLSIGreenwich LifeSciences Inc. Common Stock | $226.8M | $0.00 | — | -$1.43 | +2.26% | Buy |